(Q24243986)

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Suicide prevention in first episode psychosis: the development of a randomised controlled trial of cognitive therapy for acutely suicidal patients with early psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Early intervention and a five year follow up in young adults with a short duration of untreated psychosis: ethical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

A randomised multicentre trial of integrated versus standard treatment for patients with a first episode of psychotic illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Integrated treatment of first-episode psychosis: effect of treatment on family burden: OPUS trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Early detection and assertive community treatment of young psychotics: the Opus Study Rationale and design of the trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Transition rates from schizotypal disorder to psychotic disorder for first-contact patients included in the OPUS trial. A randomized clinical trial of integrated treatment and standard treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Improving 1-year outcome in first-episode psychosis: OPUS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Integrated treatment ameliorates negative symptoms in first episode psychosis--results from the Danish OPUS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Prediction and prevention of transition to psychosis in young people at incipient risk for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Randomized, double-blind trial of olanzapine versus placebo in patients prodromally symptomatic for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Two-year outcome in first-episode psychosis treated according to an integrated model. Is immediate neuroleptisation always needed?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

The Lambeth Early Onset (LEO) Team: randomised controlled trial of the effectiveness of specialised care for early psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Cognitive therapy and recovery from acute psychosis: a controlled trial. I. Impact on psychotic symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Risperidone in the treatment of first-episode psychotic patients: a double-blind multicenter study. Risperidone Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Early intervention for first episodes of schizophrenia: a preliminary exploration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Pharmacological long-term treatment strategies in first episode schizophrenia--study design and preliminary results of an ongoing RCT within the German Research Network on Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Correlates of cognitive deficits in first episode schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

HIT, hallucination focused integrative treatment as early intervention in psychotic adolescents with auditory hallucinations: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Antipsychotic drug effects on brain morphology in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Impact of phase-specific treatment of first episode of psychosis on Wisconsin Quality of Life Index (client version).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

EPPIC: an evolving system of early detection and optimal management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Monitoring and care of young people at incipient risk of psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

A Non-neuroleptic Treatment for Schizophrenia: Analysis of the Two-year Postdischarge Risk of Relapse

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Soteria and Other Alternatives to Acute Psychiatric Hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Soteria: Evaluation of a home-based treatment for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

The treatment of acute psychosis without neuroleptics: six-week psychopathology outcome data from The Soteria Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Olanzapine versus haloperidol treatment in first-episode psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Design of the BiRmingham Early Detection In untREated psyChosis Trial (REDIRECT): cluster randomised controlled trial of general practitioner education in detection of first episode psychosis [ISRCTN87898421].

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

An open trial of clozapine in neuroleptic-resistant childhood-onset schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Optimal haloperidol dosage in first-episode psychosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Impact of an early psychosis program on substance use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

A brief motivational intervention for substance misuse in recent-onset psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

An RCT of early intervention in psychosis: Croydon Outreach and Assertive Support Team (COAST).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Early psychological intervention for auditory hallucinations: an exploratory study of young people's voices groups.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Prävention der Schizophrenie - Früherkennung und -intervention bei Personen mit erhöhtem Psychoserisiko

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

A rating scale for drug-induced akathisia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Improving the quality of reporting of randomized controlled trials. The CONSORT statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Statistics notes. Trials randomised in clusters

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Problem solving and behavior modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

The Client Satisfaction Questionnaire: psychometric properties in a Dutch addict population.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

The unit of analysis error in studies about physicians' patient care behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Issues in the meta-analysis of cluster randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Olanzapine for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Measuring inconsistency in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Duration of untreated psychosis: a critical examination of the concept and its importance

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Family intervention for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Preventing severe mental illnesses--new prospects and ethical challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

The natural history and pathophysiology of treatment resistant schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Natural course of schizophrenic disorders: a 15-year followup of a Dutch incidence cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Rationale for the study of early intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

A rating scale for mania: reliability, validity and sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

COGNITIVE THERAPY IN EARLY PSYCHOSIS: A PILOT RANDOMIZED CONTROLLED TRIAL

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Cognitively oriented psychotherapy for early psychosis (COPE): A 1-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

Neuropsychological change in early phase schizophrenia during 12 months of treatment with olanzapine, risperidone, or haloperidol. The Canadian Collaborative Group for research in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Clozapine response in treatment-refractory first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

13. Early intervention with neuroleptics may decrease the l long-term morbidity of schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

The PRIME North America randomized double-blind clinical trial of olanzapine versus placebo in patients at risk of being prodromally symptomatic for psychosis. I. Study rationale and design

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Predicting relapse in schizophrenia: the development and implementation of an early signs monitoring system using patients and families as observers, a preliminary investigation*

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Treatment, expressed emotion and relapse in recent onset schizophrenic disorders.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

A randomized controlled trial of a brief intervention for families of patients with a first episode of psychosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

A controlled randomized treatment study: the effects of a cognitive remediation program on adolescents with early onset psychosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

The Quality of Life Scale: an instrument for rating the schizophrenic deficit syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

The PACE Clinic: identification and management of young people at "ultra" high risk of psychosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

The Psychosis Project: outcome and cost-effectiveness of a psychoeducational treatment programme for schizophrenic adolescents

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Psychosocial rehabilitation early after the onset of psychosis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

A randomised controlled trial of prophylactic neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

The Scottish First Episode Schizophrenia Study. II. Treatment: pimozide versus flupenthixol. The Scottish Schizophrenia Research Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Characteristics of outcome in schizophrenia at 13 years

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Cognitive Therapy and Recovery from Acute Psychosis: a Controlled Trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Cognitive therapy and recovery from acute psychosis: A controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Causes and consequences of duration of untreated psychosis in schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Randomised controlled trial of early detection and cognitive therapy for preventing transition to psychosis in high-risk individuals. Study design and interim analysis of transition rate and psychological risk factors

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Randomised controlled trial of cognitive-behavioural therapy in early schizophrenia: acute-phase outcomes.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

OPUS study: suicidal behaviour, suicidal ideation and hopelessness among patients with first-episode psychosis. One-year follow-up of a randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021

Cognitive–behavioural therapy in first-episode and early schizophrenia

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD004718.PUB2

7 January 2021